ReviewCancers2022
Rosai-Dorfman Disease between Proliferation and Neoplasia.
Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 61 citations in OpenAlex.
- Extranodal Rosai-Dorfman disease with bilateral renal involvement: A diagnostic challenge.Radiology case reports · 2026Article
- Article
- Rosai-Dorfman disease presenting as isolated cervical lymphadenopathy in a young adult: A case report.Radiology case reports · 2026Article
- Rosai-Dorfman disease mimicking molluscum contagiosum in a patient with prior kappa light chain multiple myeloma.JAAD case reports · 2026Article
- Article
- Multifocal Rosai Dorfman disease and simultaneous endometrioid ovarian cancer: a case report.Journal of medical case reports · 2026Article
- Isolated Intracranial Rosai-Dorfman Disease Mimicking Sellar Pituitary Adenoma: a case report and literature review.BMC neurology · 2026Review
- Anesthesia management for surgical excision in patients with Rosai-Dorfman disease involving multiple organs throughout the body: a case report and literature review.BMC anesthesiology · 2026Review
- Nasal Rosai-Dorfman disease: A case report and review of the literature.SAGE open medical case reports · 2026Article
- Rosai-Dorfman disease in the breast: a case report and literature review.Frontiers in oncology · 2026Review
- Cutaneous-to-Bronchial Rosai-Dorfman Disease without Lymphadenopathy: A Rare Case Report and Literature Review.Clinical, cosmetic and investigational dermatology · 2026Article
- Advances in the diagnosis and management of pediatric Langerhans cell histiocytosis and Rosai-Dorfman disease: therapies, biomarkers, and response assessment.Hematology. American Society of Hematology. Education Program · 2025Review
- Sinonasal presentations of Rosai-Dorfman disease: a scoping review.The Journal of laryngology and otology · 2025Review
- Article
- Revealing the prognostic potential of natural killer cell-related genes in hepatocellular carcinoma: the key role of NRAS.Discover oncology · 2025Article
- Nasopharyngeal Representation of Rosai-Dorfman Disease; a Case Report.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025Article
- Rosai-Dorfman Disease of the Pericardium Accompanied by Monoclonal Gammopathy: A Case Report with CT and PET Imaging Findings.Journal of the Korean Society of Radiology · 2025Article
- Case report: Primary subcutaneous Rosai-Dorfman-Destombes of the scalp with intra-cranial involvement: diagnosis and treatment of a rare case with literature review.Frontiers in neurology · 2025Article
- Rosai-Dorfman disease: A rare presentation as an isolated axillary lymphadenopathy, a case report and literature review.International journal of surgery case reports · 2025Article
- Prednisone and Vincristine for the Treatment of Pediatric Rosai-Dorfman Disease: A Case Report.Case reports in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosai-Dorfman disease (RDD) is a rare myeloproliferative disorder of histiocytes with a broad spectrum of clinical manifestations and peculiar morphologic features (accumulation of histiocytes with emperipolesis). Typically, the patient with RDD shows bilateral painless, massive cervical lymphadenopathy associated with B symptoms. Approximately 43% of patients presented with extranodal involvement. According to the 2016 revised histiocytosis classification, RDD belongs to the R group, including familial and sporadic form (classical nodal, extranodal, unclassified, or RDD associated with neoplasia or immune disease). Sporadic RDD is often self-limited. Most RDD needs only local therapies. Nevertheless, a small subpopulation of patients may be refractory to conventional therapy and die of the disease. Recent studies consider RDD a clonal neoplastic process, as approximately 1/3 of these patients harbor gene mutations involving the MAPK/ERK pathway, e.g.,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.